Abstract | OBJECTIVES: PATIENTS AND METHODS: We examined tumor tissue samples from 24 patients with high-grade gliomas (12 with and 12 without epilepsy) by immunoblot and detected variable amounts of LGI1 in tumor tissues from 9/24 (37%) patients. RESULTS: LGI1 was detected in 7/12 (58%) patients with epilepsy and in 2/12 (16%) patients without epilepsy (p = 0.0894; Fisher's exact test). Moreover, testing blood sera of five patients for antibodies against LGI1 revealed LGI1 autoantibodies in two patients, both suffering from epilepsy and expressing LGI1 in tumor tissue. CONCLUSION: Our findings suggest that there may be a preferential expression of LGI1 in high-grade glioma tumors of patients with epilepsy. We also unveil the presence of serum LGI1 autoantibodies in some patients with high-grade gliomas, where they might play an epileptogenic role.
|
Authors | Emanuela Dazzo, Elena Pasini, Sandra Furlan, Dario de Biase, Matteo Martinoni, Roberto Michelucci, Carlo Nobile, PERNO Study Group |
Journal | Clinical neurology and neurosurgery
(Clin Neurol Neurosurg)
Vol. 170
Pg. 27-33
(07 2018)
ISSN: 1872-6968 [Electronic] Netherlands |
PMID | 29723732
(Publication Type: Journal Article)
|
Copyright | Copyright © 2018 Elsevier B.V. All rights reserved. |
Chemical References |
- Autoantibodies
- Biomarkers, Tumor
- Intracellular Signaling Peptides and Proteins
- LGI1 protein, human
- Proteins
|
Topics |
- Adult
- Aged
- Astrocytoma
(blood, diagnosis, genetics)
- Autoantibodies
(blood)
- Biomarkers, Tumor
(blood, genetics)
- Brain Neoplasms
(blood, diagnosis, genetics)
- Epilepsy, Temporal Lobe
(blood, diagnosis, genetics)
- Female
- Gene Expression Regulation, Neoplastic
- Glioblastoma
(blood, diagnosis, genetics)
- Glioma
(blood, diagnosis, genetics)
- HEK293 Cells
- Humans
- Intracellular Signaling Peptides and Proteins
- Male
- Middle Aged
- Proteins
(genetics, metabolism)
- Young Adult
|